A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311Robert L. Ferris, Barbara Burtness, Yael Flamand et al.|Oral Oncology|2020Cited by 45
Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.Ranee Mehra, Robert L. Ferris, Yael Flamand et al.|Journal of Clinical Oncology|2022Cited by 12
Impact of Treatment Time on Outcome for Resected Head and Neck Squamous Cell Carcinoma by HPV StatusJohn M. Watkins, Sarah L. Mott, Rodrigo Bayon et al.|Clinical Oncology and Research|2020Cited by 1